9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-((4R,5S,E)-5-hydroxy-4-methylhex-2-en-1-yl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoicacid;(2E)-5,9-Anhydro-2,3,4,8-tetradeoxy-8-(5-hydroxy-4-methyl-2-hexen-1-yl)-3-methyl-L-talo-Non-2-enonic Acid 8-Carboxyoctyl Ester; [2E,8(2E,4R,5S)]- 5,9-Anhydro-2,3,4,8-tetradeoxy-8-(5-hydroxy-4-methyl-2-hexenyl)-3-methyl-L-talo-non-2-enonic Acid 8-Carboxyoctyl Ester; (+)-Pseudomonic acid C;
Mupirocin EP Impurity B is a fully characterized chemical compound used as a reference standard of API Mupirocin. The standard offered is compliant with regulatory guidelines. Mupirocin EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 71980-98-8
